Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹7 Cr.
Stock P/E
-3.7
P/B
0.9
Current Price
₹23.8
Book Value
₹ 26.6
Face Value
10
52W High
₹125.2
52W Low
₹ 23.8
Dividend Yield
0%

Docmode Health Tech Overview

Business

Docmode Health Technologies Ltd. (DHTL) is an Indian health-tech education company. Its core business revolves around providing online learning and skill development platforms specifically for healthcare professionals (HCPs). The company offers Continuing Medical Education (CME) programs, skill enhancement courses, and professional development content through its digital platforms. DHTL makes money primarily through subscriptions, course fees paid by individual HCPs, partnerships with medical associations, hospitals, and pharmaceutical companies for bulk enrollments, customized training solutions, and content licensing.

Revenue Mix

While specific revenue contribution breakdowns are typically found in detailed financial reports, DHTL's business model suggests the following key segments:

Online Medical Education & CME: Offering accredited and non-accredited courses, webinars, and conferences to medical practitioners across various specialities. This includes both individual subscriptions and institutional tie-ups.

Skill Enhancement & Professional Development: Focused programs designed to upskill healthcare professionals in specific areas, often in collaboration with medical bodies or industry experts.

B2B Solutions & Partnerships: Providing customized learning solutions, content, or platform access to pharmaceutical companies, hospitals, and medical organizations for their internal training and engagement programs.

Detailed revenue contribution from each segment is not publicly disclosed without access to financial statements.

Industry

Docmode operates within the rapidly growing Indian Ed-tech sector, specifically carving a niche in health-tech education and continuous professional development for healthcare practitioners. The industry is characterized by increasing digitalization of learning, demand for specialized skills, and mandatory CME requirements. DHTL competes with traditional medical colleges offering online courses, other specialized online learning platforms (both domestic and international), in-house training programs of large hospital chains, and e-learning initiatives by pharmaceutical companies. Its positioning is as a dedicated digital platform focused on providing relevant and accessible learning for medical professionals, aiming to be a preferred partner for individual HCPs and institutional clients.

MOAT

Network Effects: As more healthcare professionals and medical experts join the platform, it becomes more valuable, attracting further users (learners) and content providers.

Proprietary Content & Partnerships: Strong relationships with medical associations, key opinion leaders, and subject matter experts to develop high-quality, relevant, and accredited content.

Specialization & Focus: Deep focus on the healthcare domain allows for tailored solutions and a better understanding of the specific needs of medical professionals, potentially leading to higher engagement and retention compared to generalist platforms.

Switching Costs (moderate): For individual users, switching costs might be low for a single course. However, if certifications or ongoing professional development records are tied to the platform, or if institutions integrate it deeply into their training, switching costs could increase.

Growth Drivers

Digitalization of Education: Continued shift towards online learning, accelerated by recent global events, driving adoption among HCPs.

Mandatory CME & Skill Upgradation: Regulatory requirements for continuous medical education and the constant need for doctors to update their knowledge and skills.

Expansion of Healthcare Sector: Growth in the overall Indian healthcare market creating demand for more skilled professionals and continuous learning.

Partnerships & Collaborations: Forming strategic alliances with medical bodies, universities, hospitals, and pharmaceutical companies to expand reach and content offerings.

Geographic Expansion: Potential to expand beyond current operational areas within India or even internationally.

Introduction of New Specialities & Formats: Diversifying course offerings and exploring new learning formats (e.g., VR/AR simulations).

Risks

Intense Competition: From established ed-tech players, specialized medical education platforms, and traditional institutions entering the online space.

Content Quality & Relevance: Failure to consistently provide high-quality, up-to-date, and accredited content could lead to loss of credibility and users.

Regulatory Changes: Evolving regulations regarding online medical education, accreditations, and professional development could impact business operations.

Technology & Platform Stability: Technical glitches, data security breaches, or inability to scale the platform effectively could deter users.

Customer Acquisition Costs: High marketing and sales expenses required to acquire and retain users in a competitive market.

Dependence on Key Personnel & Experts: Reliance on specific medical experts and faculty for content creation and delivery.

Economic Downturns: Reduced discretionary spending by individuals and institutions on professional development during economic contractions.

Management & Ownership

Docmode Health Technologies Ltd. is promoted by individuals with experience in the healthcare and technology sectors. Typically, for companies of this size, promoter ownership is significant, ensuring strong alignment between management and shareholder interests. The management team likely comprises individuals with expertise in medical education, technology, and business development, aiming to leverage digital solutions for healthcare professional development. Specific details on the individual promoters' backgrounds or the exact ownership structure are not provided here but would be available in their public filings.

Outlook

Docmode Health Technologies Ltd. operates in a sector with secular growth tailwinds, driven by the increasing digitalization of education and the critical need for continuous professional development among healthcare professionals. The company's specialized focus on the medical domain provides a competitive edge in content relevance and targeted user acquisition. However, the market is highly competitive, and sustaining growth will depend on its ability to consistently deliver high-quality, accredited content, expand its network of partners, innovate its platform, and effectively manage customer acquisition costs. Success hinges on robust execution, adapting to regulatory changes, and maintaining a strong reputation among its target audience of healthcare professionals and institutions.

Docmode Health Tech Share Price

Live · NSE · Inception: 2017
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Docmode Health Tech Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

Docmode Health Tech Profit & Loss

#(Fig in Cr.) Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 7 7 12 33 40 42
Other Income 0 0 0 0 0 1
Total Income 7 7 12 33 40 43
Total Expenditure 7 6 11 29 38 42
Operating Profit 0 1 2 4 2 0
Interest 0 0 0 1 2 2
Depreciation 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0
Profit Before Tax 0 1 2 3 0 -2
Provision for Tax -0 0 1 1 0 0
Profit After Tax 0 1 1 2 0 -2
Adjustments 0 0 0 0 0 0
Profit After Adjustments 0 1 1 2 0 -2
Adjusted Earnings Per Share 1.9 3.1 5.2 8.5 0.6 -6.4

Docmode Health Tech Balance Sheet

#(Fig in Cr.) Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds -0 0 1 3 10 8
Minority's Interest 0 0 0 0 0 0
Borrowings 0 1 3 4 4 1
Other Non-Current Liabilities -0 0 0 0 0 0
Total Current Liabilities 2 4 5 9 15 29
Total Liabilities 2 6 10 17 30 39
Fixed Assets 0 0 0 0 1 1
Other Non-Current Assets 0 0 2 3 10 13
Total Current Assets 2 5 8 14 19 25
Total Assets 2 6 10 17 30 39

Docmode Health Tech Cash Flow

#(Fig in Cr.) Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 0 0 0 0 3
Cash Flow from Operating Activities 0 -0 -2 -1 5 7
Cash Flow from Investing Activities -0 -0 -2 -2 -8 -4
Cash Flow from Financing Activities 0 1 3 3 6 -4
Net Cash Inflow / Outflow -0 0 -0 0 3 -1
Closing Cash & Cash Equivalent 0 0 0 0 3 2

Docmode Health Tech Ratios

# Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 1.92 3.15 5.24 8.5 0.6 -6.45
CEPS(Rs) 2.22 3.35 5.38 8.59 0.67 -5.5
DPS(Rs) 0 0 0 0 0 0
Book NAV/Share(Rs) -0.5 2.65 7.89 15.15 33.01 26.56
Core EBITDA Margin(%) 5.65 12.22 15.18 11.39 4.71 -1.62
EBIT Margin(%) 4.92 11.78 15.11 11.62 4.99 -0.11
Pre Tax Margin(%) 4.71 9.07 12.08 8.18 0.85 -4.7
PAT Margin (%) 4.87 7.79 7.42 5.93 0.47 -4.85
Cash Profit Margin (%) 5.63 8.29 7.61 5.99 0.53 -4.13
ROA(%) 18.12 14.77 11.79 14.5 0.8 -5.87
ROE(%) 0 293.45 99.55 80.13 2.71 -21.65
ROCE(%) 0 115.09 48.46 42.02 12.67 -0.27
Receivable days 0.38 35.22 76.08 67.22 90.15 90.47
Inventory Days 70.43 118.61 84.92 27.94 23.01 59.78
Payable days 60.54 325.09 412.77 918.1 361.85 -234.74
PER(x) 0 0 0 0 358.02 0
Price/Book(x) 0 0 0 0 6.47 1.86
Dividend Yield(%) 0 0 0 0 0 0
EV/Net Sales(x) -0.01 0.11 0.38 0.32 1.83 0.49
EV/Core EBITDA(x) -0.16 0.87 2.48 2.7 36.23 81.24
Net Sales Growth(%) 0 2.37 74.95 164.66 21.68 4.41
EBIT Growth(%) 0 144.89 124.45 103.49 -47.72 -102.32
PAT Growth(%) 0 63.8 66.64 111.3 -90.37 -1180.17
EPS Growth(%) 0 63.8 66.64 62 -92.97 -1180.21
Debt/Equity(x) -0.23 2.27 3.49 2.44 0.88 0.82
Current Ratio(x) 0.83 1.23 1.69 1.58 1.31 0.85
Quick Ratio(x) 0.14 0.48 1.19 1.29 1.14 0.47
Interest Cover(x) 23.39 4.35 4.98 3.38 1.21 -0.02
Total Debt/Mcap(x) 0 0 0 0 0.14 0.44

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +5% +52% +43% —
Operating Profit CAGR -100% -100% — —
PAT CAGR — 0% — —
Share Price CAGR -70% — — —
ROE Average -22% +20% +91% +76%
ROCE Average 0% +18% +44% +36%

Docmode Health Tech Shareholding Pattern

Latest · Mar 2026
100% held
Promoters 29.5 %
FII 0 %
DII (MF + Insurance) 0 %
Public (retail) 70.5 %
# Feb 2024 Mar 2024 Sep 2024 Dec 2024 Mar 2025 Sep 2025 Mar 2026
Promoter 47.4447.4447.4447.4447.4430.8629.5
FII 0.05000000
DII 0000000
Public 52.5152.5652.5652.5652.5669.1470.5
Others 0000000
Total 100100100100100100100

Docmode Health Tech Peer Comparison

Educational Institutions Edit Columns

Docmode Health Tech Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Docmode Health Tech Pros & Cons

Pros

  • Stock is trading at 0.9 times its book value
  • Company has a good return on equity (ROE) track record: 3 Years ROE 20%
  • Debtor days have improved from 361.85 to -234.74days.
  • Company has reduced debt.

Cons

  • Promoter holding is low: 29.5%.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp